Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Integrated Core Strategies (US) LLC reported a 5.20% stake in Bioxcel Therapeutics, Inc. (Schedule 13G)

Event Sep 29, 2025 · Filed Oct 1, 2025

Integrated Core Strategies (US) LLC reported a 5.20% stake in Bioxcel Therapeutics, Inc., 1,026,054 shares, as a passive investor on Sep 29, 2025. Filed Oct 1, 2025 (Schedule 13G).

Stake
5.20%
Shares
1,026,054
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC5.20%1,026,054
Millennium Management LLC5.20%1,028,053
Millennium Group Management LLC5.20%1,028,053
Israel A. Englander5.20%1,028,053

Source

View original at SEC

Related